Previous Article | Next Article 
Infection and Immunity, November 1998, p. 5073-5081, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Vaccination with Trypomastigote Surface Antigen 1-Encoding
Plasmid DNA Confers Protection against Lethal Trypanosoma
cruzi Infection
Benjamin
Wizel,
Nisha
Garg, and
Rick L.
Tarleton*
Department of Cellular Biology, University of
Georgia, Athens, Georgia 30602
Received 7 May 1998/Returned for modification 23 July 1998/Accepted 10 August 1998
DNA vaccination was evaluated with the experimental murine model of
Trypanosoma cruzi infection as a means to induce
antiparasite protective immunity, and the trypomastigote surface
antigen 1 (TSA-1), a target of anti-T. cruzi antibody and
major histocompatibility complex (MHC) class I-restricted
CD8+ cytotoxic T-lymphocyte (CTL) responses, was used as
the model antigen. Following the intramuscular immunization of
H-2b and H-2d mice with
a plasmid DNA encoding an N-terminally truncated TSA-1 lacking or
containing the C-terminal nonapeptide tandem repeats, the antibody
level, CTL response, and protection against challenge with T. cruzi were assessed. In H-2b mice,
antiparasite antibodies were induced only by immunization with the DNA
construct encoding TSA-1 containing the C-terminal repeats. However,
both DNA constructs were efficient in eliciting long-lasting CTL
responses against the protective
H-2Kb-restricted TSA-1515-522
epitope. In H-2d mice, inoculation with either
of the two TSA-1-expressing vectors effectively generated antiparasite
antibodies and primed CTLs that lysed T. cruzi-infected
cells in an antigen-specific, MHC class I-restricted, and
CD8+-T-cell-dependent manner. When TSA-1 DNA-vaccinated
animals were challenged with T. cruzi, 14 of 22 (64%)
H-2b and 16 of 18 (89%)
H-2d mice survived the infection. The ability
to induce significant murine anti-T. cruzi protective
immunity by immunization with plasmid DNA expressing TSA-1 provides the
basis for the application of this technology in the design of optimal
DNA multicomponent anti-T. cruzi vaccines which may
ultimately be used for the prevention or treatment of Chagas' disease.
*
Corresponding author. Mailing address: University of
Georgia, Department of Cellular Biology, 724 Biological Sciences
Building, Athens, GA 30602. Phone: (706) 542-3362. Fax: (706)
542-4271. E-mail: tarleton{at}cb.uga.edu.
Infection and Immunity, November 1998, p. 5073-5081, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Silveira, E. L. V., Claser, C., Haolla, F. A. B., Zanella, L. G., Rodrigues, M. M.
(2008). Novel Protective Antigens Expressed by Trypanosoma cruzi Amastigotes Provide Immunity to Mice Highly Susceptible to Chagas' Disease. CVI
15: 1292-1300
[Abstract]
[Full Text]
-
Cazorla, S. I., Becker, P. D., Frank, F. M., Ebensen, T., Sartori, M. J., Corral, R. S., Malchiodi, E. L., Guzman, C. A.
(2008). Oral Vaccination with Salmonella enterica as a Cruzipain-DNA Delivery System Confers Protective Immunity against Trypanosoma cruzi. Infect. Immun.
76: 324-333
[Abstract]
[Full Text]
-
Hoft, D. F., Eickhoff, C. S., Giddings, O. K., Vasconcelos, J. R. C., Rodrigues, M. M.
(2007). Trans-Sialidase Recombinant Protein Mixed with CpG Motif-Containing Oligodeoxynucleotide Induces Protective Mucosal and Systemic Trypanosoma cruzi Immunity Involving CD8+ CTL and B Cell-Mediated Cross-Priming. J. Immunol.
179: 6889-6900
[Abstract]
[Full Text]
-
Giddings, O. K., Eickhoff, C. S., Smith, T. J., Bryant, L. A., Hoft, D. F.
(2006). Anatomical Route of Invasion and Protective Mucosal Immunity in Trypanosoma cruzi Conjunctival Infection.. Infect. Immun.
74: 5549-5560
[Abstract]
[Full Text]
-
Miyahira, Y., Takashima, Y., Kobayashi, S., Matsumoto, Y., Takeuchi, T., Ohyanagi-Hara, M., Yoshida, A., Ohwada, A., Akiba, H., Yagita, H., Okumura, K., Ogawa, H.
(2005). Immune Responses against a Single CD8+-T-Cell Epitope Induced by Virus Vector Vaccination Can Successfully Control Trypanosoma cruzi Infection. Infect. Immun.
73: 7356-7365
[Abstract]
[Full Text]
-
Araujo, A. F. S., de Alencar, B. C. G., Vasconcelos, J. R. C., Hiyane, M. I., Marinho, C. R. F., Penido, M. L. O., Boscardin, S. B., Hoft, D. F., Gazzinelli, R. T., Rodrigues, M. M.
(2005). CD8+-T-Cell-Dependent Control of Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain after Immunization with Recombinant Proteins Based on Amastigote Surface Protein 2. Infect. Immun.
73: 6017-6025
[Abstract]
[Full Text]
-
Martin, D. L., Tarleton, R. L.
(2005). Antigen-Specific T Cells Maintain an Effector Memory Phenotype during Persistent Trypanosoma cruzi Infection. J. Immunol.
174: 1594-1601
[Abstract]
[Full Text]
-
Lieke, T., Graefe, S. E. B., Klauenberg, U., Fleischer, B., Jacobs, T.
(2004). NK Cells Contribute to the Control of Trypanosoma cruzi Infection by Killing Free Parasites by Perforin-Independent Mechanisms. Infect. Immun.
72: 6817-6825
[Abstract]
[Full Text]
-
Bhatia, V., Sinha, M., Luxon, B., Garg, N.
(2004). Utility of the Trypanosoma cruzi Sequence Database for Identification of Potential Vaccine Candidates by In Silico and In Vitro Screening. Infect. Immun.
72: 6245-6254
[Abstract]
[Full Text]
-
Agusti, R., Paris, G., Ratier, L., Frasch, A. C.C., de Lederkremer, R. M.
(2004). Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo. Glycobiology
14: 659-670
[Abstract]
[Full Text]
-
Dumonteil, E., Escobedo-Ortegon, J., Reyes-Rodriguez, N., Arjona-Torres, A., Ramirez-Sierra, M. J.
(2004). Immunotherapy of Trypanosoma cruzi Infection with DNA Vaccines in Mice. Infect. Immun.
72: 46-53
[Abstract]
[Full Text]
-
Boscardin, S. B., Kinoshita, S. S., Fujimura, A. E., Rodrigues, M. M.
(2003). Immunization with cDNA Expressed by Amastigotes of Trypanosoma cruzi Elicits Protective Immune Response against Experimental Infection. Infect. Immun.
71: 2744-2757
[Abstract]
[Full Text]
-
Garg, N., Tarleton, R. L.
(2002). Genetic Immunization Elicits Antigen-Specific Protective Immune Responses and Decreases Disease Severity in Trypanosoma cruzi Infection. Infect. Immun.
70: 5547-5555
[Abstract]
[Full Text]
-
Katae, M., Miyahira, Y., Takeda, K., Matsuda, H., Yagita, H., Okumura, K., Takeuchi, T., Kamiyama, T., Ohwada, A., Fukuchi, Y., Aoki, T.
(2002). Coadministration of an Interleukin-12 Gene and a Trypanosoma cruzi Gene Improves Vaccine Efficacy. Infect. Immun.
70: 4833-4840
[Abstract]
[Full Text]
-
Ouaissi, A., Guilvard, E., Delneste, Y., Caron, G., Magistrelli, G., Herbault, N., Thieblemont, N., Jeannin, P.
(2002). The Trypanosoma cruzi Tc52-Released Protein Induces Human Dendritic Cell Maturation, Signals Via Toll-Like Receptor 2, and Confers Protection Against Lethal Infection. J. Immunol.
168: 6366-6374
[Abstract]
[Full Text]
-
Planelles, L., Thomas, M. C., Alonso, C., Lopez, M. C.
(2001). DNA Immunization with Trypanosoma cruzi HSP70 Fused to the KMP11 Protein Elicits a Cytotoxic and Humoral Immune Response against the Antigen and Leads to Protection. Infect. Immun.
69: 6558-6563
[Abstract]
[Full Text]
-
Fujimura, A. E., Kinoshita, S. S., Pereira-Chioccola, V. L., Rodrigues, M. M.
(2001). DNA Sequences Encoding CD4+ and CD8+ T-Cell Epitopes Are Important for Efficient Protective Immunity Induced by DNA Vaccination with a Trypanosoma cruzi Gene. Infect. Immun.
69: 5477-5486
[Abstract]
[Full Text]
-
Kumar, S., Tarleton, R. L.
(2001). Antigen-Specific Th1 But Not Th2 Cells Provide Protection from Lethal Trypanosoma cruzi Infection in Mice. J. Immunol.
166: 4596-4603
[Abstract]
[Full Text]
-
Sepulveda, P., Hontebeyrie, M., Liegeard, P., Mascilli, A., Norris, K. A.
(2000). DNA-Based Immunization with Trypanosoma cruzi Complement Regulatory Protein Elicits Complement Lytic Antibodies and Confers Protection against Trypanosoma cruzi Infection. Infect. Immun.
68: 4986-4991
[Abstract]
[Full Text]
-
Quanquin, N. M., Galaviz, C., Fouts, D. L., Wrightsman, R. A., Manning, J. E.
(1999). Immunization of Mice with a TolA-Like Surface Protein of Trypanosoma cruzi Generates CD4+ T-Cell-Dependent Parasiticidal Activity. Infect. Immun.
67: 4603-4612
[Abstract]
[Full Text]
-
Rodrigues, M. M., Ribeirao, M., Pereira-Chioccola, V., Renia, L., Costa, F.
(1999). Predominance of CD4 Th1 and CD8 Tc1 Cells Revealed by Characterization of the Cellular Immune Response Generated by Immunization with a DNA Vaccine Containing a Trypanosoma cruzi Gene. Infect. Immun.
67: 3855-3863
[Abstract]
[Full Text]